How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Business Services · Forecast 2027–2033
Brain Machine Interface Market
- By Technology Type: Invasive Brain Machine Interfaces, Partially Invasive Brain Machine Interfaces, Non-invasive Brain Machine Interfaces
- By Application: Medical Applications, Neuroprosthetics, Communication and Control, Gaming and Entertainment, Military and Defense
- By End User: Hospitals and Clinics, Research Institutes, Rehabilitation Centers, Consumer Electronics
- By Signal Acquisition Method: Electrocorticography (ECoG), Electroencephalography (EEG), Magnetoencephalography (MEG), Functional Near-Infrared Spectroscopy (fNIRS)
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Invasive Brain Machine Interfaces leads By Technology Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
11 chapters · 272 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.63 →
- 10 Competitive Landscape 5 sections p.163 →
- 11 Company Profiles 15 players: SWOT & benchmarking p.171 →
Full report · locked preview
Everything inside the Brain Machine Interface Market report
A complete, evidence-based study - 11 chapters and 114 sections covering market size, segmentation across 4 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Technology Type 3
Application 5
End User 4
Signal Acquisition Method 4
Companies profiled
Neuralink Corporation
Blackrock Neurotech
Synchron Inc.
NeuroPace Inc.
Medtronic plc
Boston Scientific Corporation
Cognixion Inc.
Kernel
Paradromics
Neurable Inc.
NextMind
Emotiv Inc.
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Neuralink Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Blackrock Neurotech
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Synchron Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →NeuroPace Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Medtronic plc
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Boston Scientific Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Cognixion Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Kernel
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Paradromics
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Neurable Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →NextMind
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Emotiv Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →BrainCo Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →NeuroSky Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Bitbrain
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$3,097M by 2033 · 4.2% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Invasive Brain Machine Interfaces63.8
- Partially Invasive Brain Machine Interfaces20.6
- Non-invasive Brain Machine Interfaces15.5
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$734.4M → $1,058M · 4.7%
Europe$511.9M → $685.6M · 3.7%
Asia Pacific$467.3M → $594.0M · 3.0%
Latin America$289.3M → $450.0M · 5.7%
Middle East and Africa$222.5M → $283.0M · 3.0%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →4.182026
4.182027
4.202028
4.212029
4.222030
4.232031
4.252032
4.252033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Neuralink Corporation14.4
- Blackrock Neurotech17.0
- Synchron Inc.8.8
- NeuroPace Inc.6.0
- Medtronic plc8.4
- Boston Scientific Corporation17.4
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Technology Type36.0%
Application23.9%
End User22.6%
Signal Acquisition Method17.5%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America34.5
- Europe22.3
- Asia Pacific19.3
- Latin America14.7
- Middle East and Africa9.2
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Neuralink Corporation | 83 | 78 | 76 | 83 | 76 | 97 | 82 |
| Blackrock Neurotech | 75 | 74 | 69 | 84 | 73 | 89 | 77 |
| Synchron Inc. | 83 | 76 | 71 | 65 | 81 | 85 | 77 |
| NeuroPace Inc. | 69 | 72 | 73 | 72 | 62 | 65 | 69 |
| Medtronic plc | 55 | 74 | 69 | 58 | 59 | 63 | 63 |
| Boston Scientific Corporation | 59 | 48 | 46 | 51 | 49 | 70 | 54 |
| Cognixion Inc. | 50 | 46 | 49 | 44 | 46 | 46 | 47 |
| Kernel | 57 | 46 | 43 | 36 | 45 | 39 | 44 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Neuralink Corporation
- Blackrock Neurotech
- Synchron Inc.
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Neuralink Corporation | ◐ | ◐ | ◐ | ◐ | ◐ | ✓ |
| Blackrock Neurotech | ✓ | ◐ | ✓ | ◐ | ✓ | ✓ |
| Synchron Inc. | ✓ | ◐ | − | ◐ | ✓ | ✓ |
| NeuroPace Inc. | ◐ | ◐ | ◐ | ✓ | ◐ | − |
| Medtronic plc | − | ◐ | − | ◐ | − | ◐ |
| Boston Scientific Corporation | − | ◐ | ◐ | ◐ | ◐ | − |
| Cognixion Inc. | ◐ | ◐ | ◐ | − | − | ◐ |
| Kernel | ◐ | − | − | − | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Neuralink Corporation82
2Blackrock Neurotech77
3Synchron Inc.77
4NeuroPace Inc.69
5Medtronic plc63
6Boston Scientific Corporation54
7Cognixion Inc.47
8Kernel44
Competitive tiers
§8.4 · p.172 →Leader1
Set the pace on share, breadth and innovation.
Neuralink Corporation
Challenger3
Strong scale, closing on the leaders.
Blackrock NeurotechSynchron Inc.NeuroPace Inc.
Contender1
Focused players with pockets of strength.
Medtronic plc
Niche3
Specialists in a single segment or region.
Boston Scientific CorporationCognixion Inc.Kernel
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Technology Type in North America, then scale across Brain Machine Interface Market — a $536M beachhead inside a $7.79B market.
Beachhead (SOM)$536Mobtainable near-term
Serviceable (SAM)$2.85Breachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale5 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion90 fit
Invasive Brain Machine Interfaces
Best fit — highest urgency & budget in Technology Type.
Economic buyer81 fit
Partially Invasive Brain Machine Interfaces
Strong fit — clear ROI and a fast path to value.
End user68 fit
Non-invasive Brain Machine Interfaces
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Technology Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Application & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + End User
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales42%
Partner / channel29%
Digital / self-serve21%
Marketplaces8%
Positioning & messaging
§GTM 2 · p.194 →For Technology Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Brain Machine Interface Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified41%
Sales qualified21%
Evaluation12%
Closed-won7%
$21.0KCAC
$82KLTV
3.9:1LTV : CAC
< 4 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Brain Machine Interface Market is a resilient opportunity — $4.41B by 2033, compounding at 4.1%.
TAM · 2025$3.21Btoday
TAM · 2033$4.41Bforecast
CAGR4.1%2027–2033
Cumulative$34.0Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$4.41BTotal addressable market
SAM$1.62BServiceable available market
SOM$287MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →4.1% CAGR
Demand compounds through 2033, outpacing GDP across Technology Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Technology Type moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$4.41BLarge & growingTAM by 2033 at 4.1% CAGR
$1.62BServiceable nowreachable with today’s model
$287MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$3.44BBear2.6% CAGR
$4.41BBase4.1% CAGR
$5.64BBull5.4% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Application optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Brain Machine Interface Market — a $10.2B market by 2033. Plan: grow share from 7.9% to 15.1%.
Market size · 2033$10.2Btotal addressable
Market CAGR9.8%2027–2033
Target share15.1%from 7.9% today
Revenue ambition$1.54Bby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 7.9% | 15.1% | On track |
| Revenue | $752M | $1.54B | Behind |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | Behind |
| Segment coverage | 2 of 4 axes | 4 of 4 axes | On track |
| Gross margin | 29.3% | 38.5% | On track |
| Customer retention | 87.5% | 92.8% | At risk |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Technology Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Application capability
A defensible second engine — invest in Application to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Technology Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Application
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $160M capacity & capability investment
- Greenlight bolt-on M&A in Application
- Authorise North America expansion plan
- Fund R&D program for Technology Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAt risk
- Competitive share lossOn track
- Input-cost & supply riskAhead
- Regulatory / policy changeOn track
- Execution & talentOn track
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Brain Machine Interface Market conversation — a $1.37B market you can size, segment and defend in minutes.
Market size · 2033$1.37Btotal opportunity
Growth10.5%CAGR to 2033
Addressable buyers1,522+accounts in scope
Typical ROI6.2×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Technology Type
Goal Grow share in Technology Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →6.2×return on cost, year one
< 3 mopayback period
$42K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
Neuralink CorporationBlackrock NeurotechSynchron Inc.NeuroPace Inc.Medtronic plcBoston Scientific CorporationCognixion Inc.Kernel+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Brain Machine Interface Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Brain Machine Interface Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Business Services · scroll →Brain Mapping Instrument Market
Market size, share, segmentation and regional forecast.
$3.6B market · 2025 base year
View reportBrain Mint Market
Market size, share, segmentation and regional forecast.
$421M market · 2025 base year
View reportBrain Monitoring Equipments Market
Market size, share, segmentation and regional forecast.
$402M market · 2025 base year
View reportBrain Monitoring System Market
Market size, share, segmentation and regional forecast.
$3.7B market · 2025 base year
View reportBrain Protein Hydrolysate Market
Market size, share, segmentation and regional forecast.
$2.0B market · 2025 base year
View reportBrain Receptor Imaging Agent Market
Market size, share, segmentation and regional forecast.
$5.1B market · 2025 base year
View reportBrain Signal Analysis Software Market
Market size, share, segmentation and regional forecast.
$2.9B market · 2025 base year
View reportBrain Topography Market
Market size, share, segmentation and regional forecast.
$1.4B market · 2025 base year
View reportBrain Tumor Diagnosis & Treatment Market
Market size, share, segmentation and regional forecast.
$4.1B market · 2025 base year
View reportBrain Tumor Treatm Market
Market size, share, segmentation and regional forecast.
$723M market · 2025 base year
View reportBrain-Computer Interface Hand Rehabilitation Robot Market
Market size, share, segmentation and regional forecast.
$5.2B market · 2025 base year
View reportBrain-like computing chips Market
Market size, share, segmentation and regional forecast.
$4.1B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report ships as a formatted PDF, a fully editable XLSX containing all underlying data tables, and a presentation-ready PPT deck - so you can re-chart, re-model, or drop any figure straight into your own deck.